MX2018013545A - Antimicrobianos y metodos de preparacion y uso de los mismos. - Google Patents
Antimicrobianos y metodos de preparacion y uso de los mismos.Info
- Publication number
- MX2018013545A MX2018013545A MX2018013545A MX2018013545A MX2018013545A MX 2018013545 A MX2018013545 A MX 2018013545A MX 2018013545 A MX2018013545 A MX 2018013545A MX 2018013545 A MX2018013545 A MX 2018013545A MX 2018013545 A MX2018013545 A MX 2018013545A
- Authority
- MX
- Mexico
- Prior art keywords
- making
- methods
- antimicrobials
- same
- tautomer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La presente divulgación se refiere en general al campo de los compuestos antimicrobianos y a los métodos para prepararlos y usarlos. Estos compuestos son útiles para tratar, prevenir, reducir el riesgo y retrasar la aparición de infecciones microbianas en humanos y animales. En algunas modalidades, la presente divulgación proporciona un compuesto de Fórmula (I): (ver Fórmula) o un tautómero del mismo o una sal farmacéuticamente aceptable del compuesto o tautómero.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662333049P | 2016-05-06 | 2016-05-06 | |
US201662385771P | 2016-09-09 | 2016-09-09 | |
US201762444278P | 2017-01-09 | 2017-01-09 | |
US201762485760P | 2017-04-14 | 2017-04-14 | |
PCT/US2017/031336 WO2017193017A1 (en) | 2016-05-06 | 2017-05-05 | Antimicrobials and methods of making and using same |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018013545A true MX2018013545A (es) | 2019-08-14 |
Family
ID=58709636
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018013545A MX2018013545A (es) | 2016-05-06 | 2017-05-05 | Antimicrobianos y metodos de preparacion y uso de los mismos. |
Country Status (8)
Country | Link |
---|---|
US (1) | US10815237B2 (es) |
EP (1) | EP3452478A1 (es) |
JP (1) | JP2019516690A (es) |
CN (1) | CN109790165A (es) |
CA (1) | CA3023444A1 (es) |
MX (1) | MX2018013545A (es) |
TW (1) | TW201808956A (es) |
WO (1) | WO2017193017A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019515041A (ja) * | 2016-05-06 | 2019-06-06 | メリンタ セラピューティクス、 インコーポレイテッドMelinta Therapeutics, Inc. | 抗菌剤ならびにそれを作製および使用する方法 |
US20210253589A1 (en) | 2018-06-06 | 2021-08-19 | BioVersys AG | Aminomethylamidine and methylamidine antimicrobial compounds |
US20210253577A1 (en) * | 2018-06-06 | 2021-08-19 | BioVersys AG | Biodefense agents |
US20240239800A1 (en) | 2018-12-07 | 2024-07-18 | BioVersys AG | Pyrrolo[2,3-d]pyrimidin-2-one antimicrobial compounds |
JP2023501575A (ja) * | 2019-11-13 | 2023-01-18 | カーザ グローバル, エルエルシー | 抗菌化合物及び方法 |
CN111374151A (zh) * | 2020-03-19 | 2020-07-07 | 西南大学 | 一种含taa的杀菌、抗蛋白吸附以及特异性识别多功能材料的制备方法 |
US11525297B2 (en) | 2020-06-30 | 2022-12-13 | Brose Fahrzeugteile Se & Co. Kommanditgesellschaft, Bamberg | Integrated window regulator and method of making the same |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5763263A (en) * | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
ES2675798T3 (es) | 2009-10-16 | 2018-07-12 | Melinta Therapeutics, Inc. | Compuestos antimicrobianos y métodos para fabricar y usar los mismos |
JP6317669B2 (ja) | 2011-04-15 | 2018-04-25 | メリンタ セラピューティクス インコーポレイテッド | 抗菌化合物ならびにそれを作製および使用する方法 |
US10106543B2 (en) * | 2013-09-09 | 2018-10-23 | Melinta Therapeutics, Inc. | Antimicrobial compounds and methods of making and using the same |
-
2017
- 2017-05-05 MX MX2018013545A patent/MX2018013545A/es unknown
- 2017-05-05 JP JP2018558297A patent/JP2019516690A/ja active Pending
- 2017-05-05 CA CA3023444A patent/CA3023444A1/en not_active Abandoned
- 2017-05-05 EP EP17723896.1A patent/EP3452478A1/en not_active Withdrawn
- 2017-05-05 CN CN201780039602.XA patent/CN109790165A/zh active Pending
- 2017-05-05 US US16/099,047 patent/US10815237B2/en active Active
- 2017-05-05 WO PCT/US2017/031336 patent/WO2017193017A1/en unknown
- 2017-05-08 TW TW106115159A patent/TW201808956A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
US20190194205A1 (en) | 2019-06-27 |
WO2017193017A1 (en) | 2017-11-09 |
EP3452478A1 (en) | 2019-03-13 |
TW201808956A (zh) | 2018-03-16 |
CN109790165A (zh) | 2019-05-21 |
JP2019516690A (ja) | 2019-06-20 |
US10815237B2 (en) | 2020-10-27 |
CA3023444A1 (en) | 2017-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018013545A (es) | Antimicrobianos y metodos de preparacion y uso de los mismos. | |
PH12017501646A1 (en) | Antimicrobial compounds and methods of making and using the same | |
PH12016500453A1 (en) | Antimicrobial compounds and methods of making and using the same | |
PH12016502092A1 (en) | Antimicrobial compounds and methods of making and using the same | |
PH12017502407B1 (en) | Fused pyrimidine compound or salt thereof | |
SG11201901061QA (en) | Heterocyclic compound | |
MY173518A (en) | Antimicrobial compounds and methods of making and using the same | |
MY176900A (en) | Antimicrobial compounds and methods of making and using the same | |
EA201591362A1 (ru) | Соединения и способы лечения бактериальных инфекций | |
PH12015502375B1 (en) | Antimicrobial compounds and methods of making and using the same | |
WO2015110969A3 (en) | Nitrogen containing compounds and their use as antibacterial agents | |
ZA202002093B (en) | Antibacterial compounds | |
MX2019006768A (es) | Peptidos antimicrobianos. | |
MY165011A (en) | Antimicrobial compounds and methods of making and using the same | |
MX2022006229A (es) | Composiciones y metodos para el tratamiento de resistencia a la insulina. | |
MX2015005753A (es) | Agentes antimicrobianos. | |
PH12019502509A1 (en) | Compounds and methods for treating bacterial infections | |
EP3327001A4 (en) | NOVEL COMPOUND HAVING BLT INHIBITORY ACTIVITY AND COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES, CONTAINING THE SAME AS ACTIVE INGREDIENT | |
MX2019003545A (es) | Compuestos heterociclicos y uso de los mismos para prevenir o tratar infecciones bacterianas. | |
WO2019234509A3 (en) | Aminomethylamidine and methylamidine antimicrobial compounds | |
WO2015035234A3 (en) | Anti-microbial compounds and compositions | |
NZ626112A (en) | Triazinone compound and t-type calcium channel inhibitor | |
MX2019009362A (es) | Compuestos heterociclicos novedosos y sus usos en la prevencion o el tratamiento de infecciones bacterianas. | |
MX2019010112A (es) | Compuestos antibacterianos. | |
PH22015000212Y1 (en) | A hapal (drimys piperata) capsule for treating infections caused by staphylococcus aureus and escherichiacoli |